NYSE: THCTenet Healthcare Corp Stock
$98.26+0.40 (+0.41%)
Updated Apr 24, 2024
THC Price
$98.26
Fair Value Price
N/A
Market Cap
$9.83B
52 Week Low
$51.04
52 Week High
$107.80
P/E
16.35x
P/B
6.11x
P/S
0.37x
PEG
0.55x
Dividend Yield
N/A
Revenue
$20.56B
Earnings
$611.00M
Gross Margin
100%
Operating Margin
8.84%
Profit Margin
3%
Debt to Equity
14.18
Operating Cash Flow
$2B
Beta
1.5
Next Earnings
Apr 30, 2024
Ex-Dividend
N/A
Next Dividend
N/A
THC Overview
Tenet Healthcare Corporation is a diversified healthcare services company. Its general hospitals offer acute, intensive, and critical care services, operating and recovery rooms, coronary care units, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. The company was incorporated in 1975 and is headquartered in Dallas, TX.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how THC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
THC ($98.26) is trading above its intrinsic value of $95.33, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
THC is good value based on its earnings relative to its share price (16.35x), compared to the US market average (41.27x)
P/E vs Market Valuation
THC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more THC due diligence checks available for Premium users.
Be the first to know about important THC news, forecast changes, insider trades & much more!
THC News
Valuation
THC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
16.35x
Industry
-2.13x
Market
41.27x
THC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
THC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
THC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.11x
Industry
4.61x
THC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
THC price to earnings growth (PEG)
For valuing profitable companies with growth potential
THC is good value based... subscribe to Premium to read more.
PEG Value Valuation
THC's financial health
Profit margin
Revenue
$5.4B
Net Income
$244.0M
Profit Margin
4.5%
THC's Earnings (EBIT) of $1.82B... subscribe to Premium to read more.
Interest Coverage Financials
THC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$28.3B
Liabilities
$22.8B
Debt to equity
14.18
THC's short-term assets ($7.17B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
THC's long-term liabilities ($18.04B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
THC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
THC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$824.0M
Investing
-$333.0M
Financing
-$317.0M
THC's operating cash flow ($2.37B)... subscribe to Premium to read more.
Debt Coverage Financials
THC vs Medical Care Facility Stocks
Tenet Healthcare Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.